SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
NSPR

InspireMD, Inc. (NSPR)

NASDAQ: NSPR · Real-Time Price · USD
Healthcare · Medical Devices
$0.67+$0.02 (+2.72%)
 
Market cap
$36.1M
Insider Score
Analyst consensus
Market Cap$36.14M-65.9%
Revenue (ttm)$10.56M
Net Income-$49.54M
EPS-$0.57
Shares Out54.13M
PE Ration/a
Forward PE-1.82
Dividendn/a
Ex-Dividend Daten/a
Volume268,796
Open$0.65
Previous Close$0.65
Day's Range$0.62 - $0.69
52-Week Range$0.43 - $2.17
Betan/a
AnalystsBuy
Price Target$2.67(+299.38%)
Earnings DateNov 12, 2026
+3.08% (1D)
No price history available.

About NSPR

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.

Address
6303 Waterford District Drive, Miami, FL, 33126, United States
Market Cap
36 million
Employees
127
Industrial Classification
Medical Devices

InspireMD, Inc. Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
46th Percentile Overall Score
NSPR InsiderScore:67 / 99

InspireMD, Inc. scored higher than 46% of companies evaluated by InsiderBuying, and ranked 28th out of 50 stocks in the healthcare sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at InspireMD, Inc. bought $455.0K of stock across 5 purchases in the last 90 days, the largest of them $200.0K.

Stake Increase

The average purchase added about 26% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$455.00K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
+2.72%
5 Days
-16.54%
1 Month
+51.75%
6 Months
-33.23%
1 Year
-65.93%

$NSPR stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in NSPR holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by NSPR's directors and management

Net Shares Purchased by Insiders−800k−400k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

NSPR Estimated quarterly lobbying spending

Source: U.S. Senate LDA

NSPR Revenue by Segment or Geography

$11.65MTotal
Selling and marketing (S&M)$2.39M20.54%
Material and Labor$1.73M14.80%
Other G&A$1.47M12.58%
Clinical trials$1.22M10.50%
Payroll and Benefits$1.19M10.17%
Inventory write-off$1.08M9.31%
Other R&D$1.07M9.23%
Restructuring and other$1.07M9.22%
Other S&M$425.00K3.65%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New NSPR patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to NSPR from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from NSPR’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
67.13
Analyst Ratings
40% of score
85
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
5
Sells
0
Buy Value
$455.00K
Distinct Buyers
5

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.